Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Edwards Lifesciences Corp., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

Microsoft Excel
Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Accounts payable
Accrued and other liabilities
Accounts payable and accrued liabilities (legacy)
Operating lease liabilities, current portion
Short-term debt
Contingent consideration liabilities
Current liabilities
Long-term debt
Contingent consideration liabilities
Taxes payable
Operating lease liabilities, long-term portion
Uncertain tax positions
Litigation settlement accrual
Other liabilities
Long-term liabilities
Total liabilities
Preferred stock, $.01 par value, no shares outstanding
Common stock, $1.00 par value
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Treasury stock, at cost
Stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).


Liabilities Trends
Total liabilities exhibit fluctuations over the periods, starting at approximately $2.04 billion and generally increasing to about $2.67 billion by the end of 2021. The increase is somewhat volatile but shows a rising trend. Current liabilities demonstrate similar volatility, peaking around late 2017 at approximately $1.4 billion and showing a moderate increase again toward the end of the timeline. Long-term liabilities fluctuate around $1.3 to $1.7 billion, with a notable rise between 2019 and mid-2020, peaking above $1.7 billion, then stabilizing near $1.63 billion by the end of 2021.
Debt and Lease Obligations
Short-term debt appears only in the 2017 and early 2018 periods, consistently around $598 million, after which it ceases to be reported. Long-term debt remains relatively stable throughout the periods, hovering just under $600 million. Operating lease liabilities both current and long-term portions show modest growth, with current portions ranging from about $22 million to $27 million, and long-term portions increasing from roughly $50 million to near $69 million by the close of 2021.
Accounts Payable and Accrued Liabilities
The legacy accounts payable and accrued liabilities display variability, with values generally between $560 million and $870 million; however, data for later periods in 2021 is incomplete. Separate accounts payable and accrued liabilities figures for the last two quarters indicate substantial increases to $139.5 million and $204.5 million for accounts payable, and relatively stable values near $802 million for accrued liabilities.
Contingent Consideration Liabilities
Contingent consideration liabilities show a significant decline, from around $196 million in early 2017 to $62 million by the end of 2021, suggesting a reduction in contingent obligations over the years.
Tax-Related Liabilities
Taxes payable peak early around $394 million in 2017, then decline to stabilize near $190 million toward the later periods. Uncertain tax positions steadily increase from roughly $125 million to about $259 million, indicating growing unresolved tax uncertainties.
Litigation and Other Liabilities
The litigation settlement accrual appears only from mid-2020 onward, showing a gradual decrease from $233 million to $191 million. Other liabilities fluctuate notably; after a decline to $150 million in 2018, they spike to over $465 million in mid-2020, then decrease again to around $267 million by the end of 2021.
Equity Components
Common stock remains relatively steady, increasing slightly from $243 million to $642 million over the periods, signaling issuance or adjustments. Additional paid-in capital shows a general upward trend from $1.21 billion to $1.70 billion, with some variability in 2020. Retained earnings experience significant growth, doubling from approximately $4.15 billion to $6.07 billion, reflecting ongoing profitability accumulation. Accumulated other comprehensive loss remains negative throughout, ranging from about -$181 million to near -$158 million, showing modest fluctuations. Treasury stock values dramatically decrease in magnitude (less negative) initially, then deepen losses again in later periods, indicating fluctuating repurchases or retirements.
Overall Financial Position
Total stockholders’ equity has generally increased from $2.74 billion to $5.84 billion, demonstrating strengthening equity base despite volatility in certain components. The sum of total liabilities and stockholders’ equity grows consistently from $4.78 billion to $8.50 billion, reflecting overall company growth or asset expansion.